Follow the people · Insider

PS

Paul J. Sekhri

Insider · Director · VEEV

Paul J. Sekhri files insider transactions with the SEC as a director of Veeva Systems (VEEV). We hold 1 disclosed purchase or sale filed since 9 November 2007, 1 of them in the last 90 days.

  • Files forVEEV
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure3 September 2026

Positions held

10 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 2 September 20141 September 2026Director · Veeva Systems (VEEV)131 Form 4 lines · source: SEC Form 4
  • Filed 30 July 20263 August 2026Director · Apnimed (APMD)9 Form 4 lines · source: SEC Form 4
  • Filed 27 February 202417 February 2026Pres, CEO and Exec Chairperson · vTv Therapeutics (VTVT)7 Form 4 lines · source: SEC Form 4
  • Filed 24 May 20222 December 2024Director · Longboard Pharmaceuticals (LBPH)7 Form 4 lines · source: SEC Form 4
  • Filed 19 May 202219 May 2022Director · Axcella Health (AXLA)1 Form 4 line · source: SEC Form 4
  • Filed 2 October 202028 July 2021Director · BiomX (PHGE)4 Form 4 lines · source: SEC Form 4
  • Filed 2 January 20182 January 2020Director · Alpine Immune Sciences (ALPN)3 Form 4 lines · source: SEC Form 4
  • Filed 22 September 20159 December 2016Director · Enumeral Biomedical Holdings (ENUM)5 Form 4 lines · source: SEC Form 4
  • Filed 12 September 201612 September 2016Director · Nivalis Therapeutics (NVLS)1 Form 4 line · source: SEC Form 4
  • Filed 7 November 200730 April 2010Director · ARYx Therapeutics (ARYX)3 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.